Taken together, our study provides new insight into understanding the unique cross-talk within the proximal tubules mediated by exosomes and the novel regulation mechanism of miR-1269b–FBLN1 that can be used to explain DN development and be potential biomarkers in clinical T2DM patients (Figure 7). Here, FBLN1 is linked to liver dysplastic nodule.